Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
6(55%)
Results Posted
75%(3 trials)

Phase Distribution

Ph phase_2
3
27%
Ph phase_3
1
9%
Ph not_applicable
6
55%
Ph phase_4
1
9%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
3(27.3%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
6(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

11

all time

Status Distribution
Active(6)
Completed(4)
Other(1)

Detailed Status

Completed4
Recruiting4
Active, not recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
6
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (27.3%)
Phase 31 (9.1%)
Phase 41 (9.1%)
N/A6 (54.5%)

Trials by Status

completed436%
active_not_recruiting218%
recruiting436%
unknown19%

Recent Activity

6 active trials
Showing 5 of 11
completedphase_2

An Exploratory Study of PQ Grass 27600 SU

NCT04687059
recruitingphase_2

LSD Treatment for Persons With Alcohol Use Disorder

NCT05474989
recruitingnot_applicable

A Novel Oral Synbiotic Formula in Reducing Advanced Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene Markers

NCT05592886
active_not_recruitingnot_applicable

Evaluate the Effect of Synbiotics on MAFLD

NCT06537882
recruitingphase_2

Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN

NCT06731335
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT04687059Phase 2

An Exploratory Study of PQ Grass 27600 SU

Completed
NCT05474989Phase 2

LSD Treatment for Persons With Alcohol Use Disorder

Recruiting
NCT05592886Not Applicable

A Novel Oral Synbiotic Formula in Reducing Advanced Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene Markers

Recruiting
NCT06537882Not Applicable

Evaluate the Effect of Synbiotics on MAFLD

Active Not Recruiting
NCT06731335Phase 2

Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN

Recruiting
NCT05163496Phase 3

Frontline Clinician Psilocybin Study

Completed
NCT06560385Not Applicable

Alleviation of Alopecia in Breast Cancer Patient Using Synbiotics Formula

Recruiting
NCT04950803Not Applicable

A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Recovered COVID-19 Patients

Active Not Recruiting
NCT05481424Not Applicable

Evaluating the Potentials of Biodynamic Lighting for Home Office Workers

Completed
NCT04884776Not Applicable

Modulation of Gut Microbiota to Enhance Health and Immunity

Unknown
NCT00852969Phase 4

Niacin and Endothelial Function in Early CKD

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11